Jin David 4
4 · Fortress Biotech, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.001
2025-10-01$1.31/sh+2,711$3,549→ 1,248,604 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Total holdings include 1,230,000 shares underlying deferred restricted stock units.